The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?

Abstract

Background: The underlying changes of peripheral blood inflammatory cells (PBICs) in COVID-19 patients are little known. Moreover, the risk factors for the underlying changes of PBICs and their predicting role in severe COVID-19 patients remain uncertain. Material and methods: This retrospective study including two cohorts: the main cohort enrolling 45 patients of severe type serving as study group, and the secondary cohort enrolling 12 patients of no-severe type serving as control group. The PBICs analysis was based on blood routine and lymphocyte subsets. The inflammatory cell levels were compared among patients according to clinical classifications, disease-associated phases, as well as one-month outcomes. Results: Compared with patients of non-severe type, the patients of severe type suffered from significantly decreased counts of lymphocytes, eosinophils, basophils, but increased counts of neutrophils. These PBICs alterations got improved in recovery phase, but persisted or got worse in aggravated phase. Compared with patients in discharged group, the patients in un-discharged/died group suffered from decreased counts of total T lymphocytes, CD4 + T lymphocytes, CD8 + T lymphocytes, as well as NK cells at 2 weeks after treatment. Clinical classification-critically severe was the independently risk factor for lymphopenia (OR = 7.701, 95%CI:1.265-46.893, P = 0.027), eosinopenia (OR = 5.595, 95%CI:1.008-31.054, P = 0.049), and worse onemonth outcome (OR = 8.984; 95%CI:1.021-79.061, P = 0.048). Conclusion: Lymphopenia and eosinopenia may serve as predictors of disease severity and disease progression in COVID-19 patients, and enhancing the cellular immunity may contribute to COVID-19 treatment. Thus, PBICs might become a sentinel of COVID-19, and it deserves attention during COVID-19 treatment. IntroductionSince December 2019, an increasing number of pneumonia cases emerged in Wuhan, and rapidly spread throughout China [1]. The causative virus was officially named as 2019-novel coronavirus (2019-nCoV), and its relevant infected disease was also officially designated

Effect of obesity and body mass index on coronavirus disease 2019 severity: A systematic review and meta‐analysis

“…After full‐text review, 16 articles were selected for quantitative synthesis (Table 1). 18‐33 The median or mean age ranged from 35 to 67 years old with a mortality rate from 0% to 50%. Male predominance was found in 10 studies.…”

COVID‐19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes

“…G, In the case of vertical transmission of SARS-CoV-2, anticipated complications might involve infection of the placenta (chorioamnititis, premature membrane rupture), and adverse neonatal outcomes, such as stillbirth, neonatal asphyxia, pneumonia, and neonatal death COVID-19 patients might be caused by the pulmonary recruitment of immune cells from peripheral blood and the infiltration of lymphocytes into the airways as suggested by several authors. [33][34][35][36] The release of pro-inflammatory cytokines (such as IFN-γ and IL-6) and chemokines (such as CCL2 and CXCL10) attracts immune cells, notably monocytes and T lymphocytes, but not neutrophils, from the blood to the infected site. 22,37 This will result in lymphopenia, eosinopenia, and increased neutrophil-lymphocyte ratio in peripheral blood, 38,39 as well as ARDS in COVID-19 patients.…”

Association of immunological features with COVID-19 severity: a systematic review and meta-analysis

“…Most of our included studies found signi cant lower levels of immune cells (CD8 + T, CD4 + T, CD3 + T, B and NK cells) in severe cases compared with mild cases [2,8,12]. Only two studies reported no signi cant decrease in CD8 + T cell level [3,16], while one study reported higher levels of B cell [11] in severe cases. Synthesizing all the collected evidence, our meta-analysis results found that the levels of immune cells (CD8 + T, CD4 + T, CD3 + T, B and NK) were signi cantly lower in severe cases compared with mild cases, but Treg cell level and CD4 + /CD8 + ratio showed no signi cant differences.…”